NEOPLASIA

eISSN: 1476-5586pISSN: 1476-5586

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

Impact Factor
< 5
3
Time to Publish
time-to-publish View Chart
3  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • SJR SJR
Overview
  • Publisher
    ELSEVIER SCIENCE INC
  • Language
    English
  • Frequency
    Monthly
General Details
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 52%
4-6 37%
7-9 8%
>9 3%

Topics Covered

Cancer
P53 pathway
Bone marrow
Lung cancer
Head and neck
Glioblastoma
DNA damage
Breast cancer
Tumor microenvironment
Drug delivery
Epidermal growth factor receptor
Extracellular vesicles
Cisplatin
Mathematical model
Neuroblastoma
Gene expression
Prostate cancer
Bystander effect
Overall survival
Hepatocellular carcinoma

Recently Published Papers

FAQs

Since when has NEOPLASIA been publishing? Faqs

The NEOPLASIA has been publishing since 1999 till date.

How frequently is the NEOPLASIA published? Faqs

NEOPLASIA is published Monthly.

Who is the publisher of NEOPLASIA? Faqs

The publisher of NEOPLASIA is ELSEVIER SCIENCE INC.

How can I view the journal metrics of NEOPLASIA on editage? Faqs

For the NEOPLASIA metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of NEOPLASIA? Faqs

The eISSN number is 1476-5586 and pISSN number is 1476-5586 for NEOPLASIA.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cancer, P53 pathway, Bone marrow, Lung cancer, Head and neck, Glioblastoma, DNA damage, Breast cancer, Tumor microenvironment, Drug delivery, Epidermal growth factor receptor, Extracellular vesicles, Cisplatin, Mathematical model, Neuroblastoma, Gene expression, Prostate cancer, Bystander effect, Overall survival, Hepatocellular carcinoma.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.